<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38785952</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>Scorpion Venom Antimicrobial Peptide Derivative BmKn2-T5 Inhibits Enterovirus 71 in the Early Stages of the Viral Life Cycle <i>In Vitro</i>.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">545</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom14050545</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71), a typical representative of unenveloped RNA viruses, is the main pathogenic factor responsible for hand, foot, and mouth disease (HFMD) in infants. This disease seriously threatens the health and lives of humans worldwide, especially in the Asia-Pacific region. Numerous animal antimicrobial peptides have been found with protective functions against viruses, bacteria, fungi, parasites, and other pathogens, but there are few studies on the use of scorpion-derived antimicrobial peptides against unenveloped viruses. Here, we investigated the antiviral activities of scorpion venom antimicrobial peptide BmKn2 and five derivatives, finding that BmKn2 and its derivative BmKn2-T5 exhibit a significant inhibitory effect on EV71. Although both peptides exhibit characteristics typical of amphiphilic α-helices in terms of their secondary structure, BmKn2-T5 displayed lower cellular cytotoxicity than BmKn2. BmKn2-T5 was further found to inhibit EV71 in a dose-dependent manner in vitro. Moreover, time-of-drug-addition experiments showed that BmKn2-T5 mainly restricts EV71, but not its virion or replication, at the early stages of the viral cycle. Interestingly, BmKn2-T5 was also found to suppress the replication of the enveloped viruses DENV, ZIKV, and HSV-1 in the early stages of the viral cycle, which suggests they may share a common early infection step with EV71. Together, the results of our study identified that the scorpion-derived antimicrobial peptide BmKn2-T5 showed valuable antiviral properties against EV71 <i>in vitro</i>, but also against other enveloped viruses, making it a potential new candidate therapeutic molecule.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Zhiqiang</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0009-0007-3379-9022</Identifier><AffiliationInfo><Affiliation>Center for Evolution and Conservation Biology, Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), Guangzhou 511458, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biological and Food Processing Engineering, Huanghuai University, Zhumadian 463000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shenzhen Research Institute, Wuhan University, Shenzhen 518057, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Huijuan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Weilie</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Aili</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8124-9697</Identifier><AffiliationInfo><Affiliation>Center for Evolution and Conservation Biology, Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), Guangzhou 511458, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Zhijian</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Center for Evolution and Conservation Biology, Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), Guangzhou 511458, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan 430072, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shenzhen Research Institute, Wuhan University, Shenzhen 518057, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2023YFC2307800</GrantID><Agency>National Key Research and Development Program of China</Agency><Country /></Grant><Grant><GrantID>2023AB08097</GrantID><Agency>Key Program of Science and Technology Department of Guangxi</Agency><Country /></Grant><Grant><GrantID>RAZ24010001</GrantID><Agency>Project of Southern Marine Science and Engineering Guangdong Laboratory</Agency><Country /></Grant><Grant><GrantID>32161160303</GrantID><Agency>National Science Fund of China</Agency><Country /></Grant><Grant><GrantID>JCYJ20230807090212024</GrantID><Agency>Shenzhen Science and Technology Program of China</Agency><Country /></Grant><Grant><GrantID>2021B1212030011</GrantID><Agency>Science and Technology Plan Project of Guangdong Province of China</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012604">Scorpion Venoms</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000089882">Antimicrobial Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D012604" MajorTopicYN="Y">Scorpion Venoms</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="Y">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000089882" MajorTopicYN="Y">Antimicrobial Peptides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BmKn2-T5</Keyword><Keyword MajorTopicYN="N">EV71</Keyword><Keyword MajorTopicYN="N">antimicrobial peptides</Keyword><Keyword MajorTopicYN="N">antiviral activity</Keyword><Keyword MajorTopicYN="N">scorpion venom peptides</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>24</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>24</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>24</Day><Hour>9</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38785952</ArticleId><ArticleId IdType="pmc">PMC11117539</ArticleId><ArticleId IdType="doi">10.3390/biom14050545</ArticleId><ArticleId IdType="pii">biom14050545</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nayak G., Bhuyan S.K., Bhuyan R., Sahu A., Kar D., Kuanar A. Global emergence of Enterovirus 71: A systematic review. Beni Suef Univ. J. Basic Appl. Sci. 2022;11:78–89. doi: 10.1186/s43088-022-00258-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43088-022-00258-4</ArticleId><ArticleId IdType="pmc">PMC9188855</ArticleId><ArticleId IdType="pubmed">35730010</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Perera R., Cardosa J., Kuhn R.J., Rossmann M.G. Crystal structure of human enterovirus 71. Science. 2012;336:1274–1277. doi: 10.1126/science.1218713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1218713</ArticleId><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu K., Onintsoa Diarimalala R., Yao C., Li H., Wei Y. EV-A71 mechanism of entry: Receptors/co-receptors, related pathways and inhibitors. Viruses. 2023;15:785–808. doi: 10.3390/v15030785.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030785</ArticleId><ArticleId IdType="pmc">PMC10051052</ArticleId><ArticleId IdType="pubmed">36992493</ArticleId></ArticleIdList></Reference><Reference><Citation>Swain S.K., Gadnayak A., Mohanty J.N., Sarangi R., Das J. Does enterovirus 71 urge for effective vaccine control strategies? Challenges and current opinion. Rev. Med. Virol. 2022;32:e2322. doi: 10.1002/rmv.2322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2322</ArticleId><ArticleId IdType="pubmed">34997684</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L.Y., Tsao K.C., Hsia S.H., Shih S.R., Huang C.G., Chan W.K., Hsu K.H., Fang T.Y., Huang Y.C., Lin T.Y. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA. 2004;291:222–227. doi: 10.1001/jama.291.2.222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.291.2.222</ArticleId><ArticleId IdType="pubmed">14722149</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee H.K., Zainol M.I., Sam I.C., Chan Y.F. Recent advances in the understanding of enterovirus A71 infection: A focus on neuropathogenesis. Expert Rev. Anti Infect. Ther. 2021;19:733–747. doi: 10.1080/14787210.2021.1851194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2021.1851194</ArticleId><ArticleId IdType="pubmed">33183118</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W., Liao Q., Viboud C., Zhang J., Sun J., Wu J.T., Chang Z., Liu F., Fang V.J., Zheng Y., et al. Hand, foot, and mouth disease in China, 2008-12: An epidemiological study. Lancet Infect. Dis. 2014;14:308–318. doi: 10.1016/S1473-3099(13)70342-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagaya I., Takayama R., Hagiwara A. A large-scale epidemic of hand, foot and mouth disease associated with enterovirus 71 infection in Japan in 1978. Jpn. J. Med. Sci. Biol. 1981;34:191–196. doi: 10.7883/yoken1952.34.191.</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken1952.34.191</ArticleId><ArticleId IdType="pubmed">6273621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim C.T., Jiang L., Ma S., James L., Ang L.W. Basic reproduction number of coxsackievirus type A6 and A16 and enterovirus 71: Estimates from outbreaks of hand, foot and mouth disease in Singapore, a tropical city-state. Epidemiol. Infect. 2016;144:1028–1034. doi: 10.1017/S0950268815002137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268815002137</ArticleId><ArticleId IdType="pubmed">26374168</ArticleId></ArticleIdList></Reference><Reference><Citation>Puenpa J., Wanlapakorn N., Vongpunsawad S., Poovorawan Y. The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia-Pacific region. J. Biomed. Sci. 2019;26:75–86. doi: 10.1186/s12929-019-0573-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0573-2</ArticleId><ArticleId IdType="pmc">PMC6798416</ArticleId><ArticleId IdType="pubmed">31627753</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Liu L., Zeng S., Meng X., Lei N., Yang H., Li R., Mu X., Guo X. Inhibition of EV71 replication by an interferon-stimulated gene product L3HYPDH. Virus Res. 2024;342:199336. doi: 10.1016/j.virusres.2024.199336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2024.199336</ArticleId><ArticleId IdType="pmc">PMC10875296</ArticleId><ArticleId IdType="pubmed">38342315</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Xue Q., Yang F., Cao W., Liu P., Liu X., Zhu Z., Zheng H. Foot-and-mouth disease virus VP1 degrades YTHDF2 through autophagy to regulate IRF3 activity for viral replication. Autophagy. 2024:1–19. doi: 10.1080/15548627.2024.2330105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2024.2330105</ArticleId><ArticleId IdType="pmc">PMC11210904</ArticleId><ArticleId IdType="pubmed">38516932</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan T., Liu B., Yao H., Chen X., Yang H., Guo S., Wu B., Li X., Li X., Xun M., et al. Cathelicidin peptide analogues inhibit EV71 infection through blocking viral entry and uncoating. PLoS Pathog. 2024;20:e1011967. doi: 10.1371/journal.ppat.1011967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011967</ArticleId><ArticleId IdType="pmc">PMC10846744</ArticleId><ArticleId IdType="pubmed">38271479</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Wang X., Wang Y., Li Y., Chen Y., Wong Y.T., He J., He M.L. Secreted LRPAP1 binds and triggers IFNAR1 degradation to facilitate virus evasion from cellular innate immunity. Signal Transduct. Target. Ther. 2023;8:374–387. doi: 10.1038/s41392-023-01630-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01630-1</ArticleId><ArticleId IdType="pmc">PMC10518340</ArticleId><ArticleId IdType="pubmed">37743411</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y., Liu H., Hu D., He Q., Yao C., Li H., Hu K., Wang J. Recent advances in enterovirus A71 infection and antiviral agents. Lab. Investig. 2024;104:100298. doi: 10.1016/j.labinv.2023.100298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.labinv.2023.100298</ArticleId><ArticleId IdType="pubmed">38008182</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Zuo S., Wang B., Zhang K., Wang Y. Antimicrobial mechanisms and clinical application prospects of antimicrobial peptides. Molecules. 2022;27:2675–2704. doi: 10.3390/molecules27092675.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27092675</ArticleId><ArticleId IdType="pmc">PMC9104849</ArticleId><ArticleId IdType="pubmed">35566025</ArticleId></ArticleIdList></Reference><Reference><Citation>Xuan J., Feng W., Wang J., Wang R., Zhang B., Bo L., Chen Z.S., Yang H., Sun L. Antimicrobial peptides for combating drug-resistant bacterial infections. Drug Resist. Updat. 2023;68:100954. doi: 10.1016/j.drup.2023.100954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drup.2023.100954</ArticleId><ArticleId IdType="pubmed">36905712</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling C., Zhang Y., Li J., Chen W., Ling C. Clinical use of toxic proteins and peptides from Tian Hua Fen and scorpion venom. Curr. Protein Pept. Sci. 2019;20:285–295. doi: 10.2174/1389203719666180622100641.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389203719666180622100641</ArticleId><ArticleId IdType="pubmed">29932034</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C., Li Y., Chen G., Wu C., Wang X., Zhang Y. Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer: Opportunities and challenges. J. Zhejiang Univ. Sci. B. 2022;23:547–563. doi: 10.1631/jzus.B2101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1631/jzus.B2101019</ArticleId><ArticleId IdType="pmc">PMC9264107</ArticleId><ArticleId IdType="pubmed">35794685</ArticleId></ArticleIdList></Reference><Reference><Citation>Cain S., Loria S.F., Ben-Shlomo R., Prendini L., Gefen E. Dated phylogeny and ancestral range estimation of sand scorpions (Buthidae: Buthacus) reveal Early Miocene divergence across land bridges connecting Africa and Asia. Mol. Phylogenet. Evol. 2021;164:107212. doi: 10.1016/j.ympev.2021.107212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ympev.2021.107212</ArticleId><ArticleId IdType="pubmed">34029718</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison P.L., Abdel-Rahman M.A., Miller K., Strong P.N. Antimicrobial peptides from scorpion venoms. Toxicon. 2014;88:115–137. doi: 10.1016/j.toxicon.2014.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxicon.2014.06.006</ArticleId><ArticleId IdType="pmc">PMC7111748</ArticleId><ArticleId IdType="pubmed">24951876</ArticleId></ArticleIdList></Reference><Reference><Citation>Rincon-Cortes C.A., Bayona-Rojas M.A., Reyes-Montano E.A., Vega-Castro N.A. Antimicrobial activity developed by scorpion venoms and its peptide component. Toxins. 2022;14:740–757. doi: 10.3390/toxins14110740.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins14110740</ArticleId><ArticleId IdType="pmc">PMC9693228</ArticleId><ArticleId IdType="pubmed">36355990</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Z., He D., Wu Y., Kwok H.F., Cao Z. Scorpion venom peptides: Molecular diversity, structural characteristics, and therapeutic use from channelopathies to viral infections and cancers. Pharmacol. Res. 2023;197:106978. doi: 10.1016/j.phrs.2023.106978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2023.106978</ArticleId><ArticleId IdType="pubmed">37923027</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X., Ma C., Du Q., Wei R., Wang L., Zhou M., Chen T., Shaw C. Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: Evaluation of their antimicrobial and anticancer activities. Biochimie. 2013;95:1784–1794. doi: 10.1016/j.biochi.2013.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2013.06.003</ArticleId><ArticleId IdType="pubmed">23770440</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Q., Hou X., Wang L., Zhang Y., Xi X., Wang H., Zhou M., Duan J., Wei M., Chen T., et al. AaeAP1 and AaeAP2: Novel antimicrobial peptides from the venom of the scorpion, Androctonus aeneas: Structural characterisation, molecular cloning of biosynthetic precursor-encoding cDNAs and engineering of analogues with enhanced antimicrobial and anticancer activities. Toxins. 2015;7:219–237. doi: 10.3390/toxins7020219.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins7020219</ArticleId><ArticleId IdType="pmc">PMC4344621</ArticleId><ArticleId IdType="pubmed">25626077</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawson K.M., Lacey M.M., Strong P.N., Miller K. Improving the therapeutic index of Smp24, a venom-derived antimicrobial peptide: Increased activity against gram-negative bacteria. Int. J. Mol. Sci. 2022;23:7979–7993. doi: 10.3390/ijms23147979.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23147979</ArticleId><ArticleId IdType="pmc">PMC9320964</ArticleId><ArticleId IdType="pubmed">35887325</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilhelmelli F., Vilela N., Smidt K.S., de Oliveira M.A., da Cunha Morales Alvares A., Rigonatto M.C., da Silva Costa P.H., Tavares A.H., de Freitas S.M., Nicola A.M., et al. Activity of scorpion venom-derived antifungal peptides against planktonic cells of Candida spp. and Cryptococcus neoformans and Candida albicans biofilms. Front. Microbiol. 2016;7:1844–1858. doi: 10.3389/fmicb.2016.01844.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.01844</ArticleId><ArticleId IdType="pmc">PMC5114273</ArticleId><ArticleId IdType="pubmed">27917162</ArticleId></ArticleIdList></Reference><Reference><Citation>Parente A.M.S., Daniele-Silva A., Furtado A.A., Melo M.A., Lacerda A.F., Queiroz M., Moreno C., Santos E., Rocha H.A.O., Barbosa E.G., et al. Analogs of the scorpion venom peptide stigmurin: Structural assessment, toxicity, and increased antimicrobial activity. Toxins. 2018;10:161–177. doi: 10.3390/toxins10040161.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins10040161</ArticleId><ArticleId IdType="pmc">PMC5923327</ArticleId><ArticleId IdType="pubmed">29670004</ArticleId></ArticleIdList></Reference><Reference><Citation>Amorim-Carmo B., Daniele-Silva A., Parente A.M.S., Furtado A.A., Carvalho E., Oliveira J.W.F., Santos E.C.G., Silva M.S., Silva S.R.B., Silva-Junior A.A., et al. Potent and broad-spectrum antimicrobial activity of analogs from the scorpion peptide stigmurin. Int. J. Mol. Sci. 2019;20:623–644. doi: 10.3390/ijms20030623.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20030623</ArticleId><ArticleId IdType="pmc">PMC6387013</ArticleId><ArticleId IdType="pubmed">30709056</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Bitar A.M.H., Sarhan M., Abdel-Rahman M.A., Quintero-Hernandez V., Aoki-Utsubo C., Moustafa M.A., Possani L.D., Hotta H. Smp76, a scorpine-like peptide isolated from the venom of the scorpion Scorpio maurus palmatus, with a potent antiviral activity against hepatitis C virus and dengue virus. Int. J. Pept. Res. Ther. 2020;26:811–821. doi: 10.1007/s10989-019-09888-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10989-019-09888-2</ArticleId><ArticleId IdType="pmc">PMC7223391</ArticleId><ArticleId IdType="pubmed">32435168</ArticleId></ArticleIdList></Reference><Reference><Citation>Jlassi A., Mekni-Toujani M., Ferchichi A., Gharsallah C., Malosse C., Chamot-Rooke J., ElAyeb M., Ghram A., Srairi-Abid N., Daoud S. BotCl, the first chlorotoxin-like peptide inhibiting newcastle disease virus: The emergence of a new scorpion venom AMPs family. Molecules. 2023;28:4355–4374. doi: 10.3390/molecules28114355.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules28114355</ArticleId><ArticleId IdType="pmc">PMC10254560</ArticleId><ArticleId IdType="pubmed">37298831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghazal A., Clarke D., Abdel-Rahman M.A., Ribeiro A., Collie-Duguid E., Pattinson C., Burgoyne K., Muhammad T., Alfadhel S., Heidari Z., et al. Venomous gland transcriptome and venom proteomic analysis of the scorpion Androctonus amoreuxi reveal new peptides with anti-SARS-CoV-2 activity. Peptides. 2024;173:171139. doi: 10.1016/j.peptides.2023.171139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.peptides.2023.171139</ArticleId><ArticleId IdType="pubmed">38142817</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Cao L., Zhong M., Zhang Y., Han C., Li Q., Yang J., Zhou D., Shi W., He B., et al. Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7. PLoS ONE. 2012;7:e34947. doi: 10.1371/journal.pone.0034947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034947</ArticleId><ArticleId IdType="pmc">PMC3334916</ArticleId><ArticleId IdType="pubmed">22536342</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenfield N.J. Using circular dichroism spectra to estimate protein secondary structure. Nat. Protoc. 2006;1:2876–2890. doi: 10.1038/nprot.2006.202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2006.202</ArticleId><ArticleId IdType="pmc">PMC2728378</ArticleId><ArticleId IdType="pubmed">17406547</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagheri-Ziari S., Shahbazzadeh D., Sardari S., Sabatier J.M., Pooshang Bagheri K. Discovery of a new analgesic peptide, leptucin, from the Iranian scorpion, Hemiscorpius lepturus. Molecules. 2021;26:2580–2597. doi: 10.3390/molecules26092580.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26092580</ArticleId><ArticleId IdType="pmc">PMC8124257</ArticleId><ArticleId IdType="pubmed">33925223</ArticleId></ArticleIdList></Reference><Reference><Citation>Daelemans D., Pauwels R., De Clercq E., Pannecouque C. A time-of-drug addition approach to target identification of antiviral compounds. Nat. Protoc. 2011;6:925–933. doi: 10.1038/nprot.2011.330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2011.330</ArticleId><ArticleId IdType="pmc">PMC7086561</ArticleId><ArticleId IdType="pubmed">21637207</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Lang Y., Ji Z., Xia Z., Han Y., Cheng Y., Liu G., Sun F., Zhao Y., Gao M., et al. A scorpion venom peptide Ev37 restricts viral late entry by alkalizing acidic organelles. J. Biol. Chem. 2019;294:182–194. doi: 10.1074/jbc.RA118.005015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.005015</ArticleId><ArticleId IdType="pmc">PMC6322876</ArticleId><ArticleId IdType="pubmed">30404919</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M.L., Hsu T.A., Chen T.C., Chang S.C., Lee J.C., Chen C.C., Stollar V., Shih S.R. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology. 2002;293:386–395. doi: 10.1006/viro.2001.1310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1310</ArticleId><ArticleId IdType="pubmed">11886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S.J., Kim D.H., Mishig-Ochir T., Lee B.J. Antimicrobial peptides: Their physicochemical properties and therapeutic application. Arch. Pharm. Res. 2012;35:409–413. doi: 10.1007/s12272-012-0302-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12272-012-0302-9</ArticleId><ArticleId IdType="pubmed">22477186</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercurio F.A., Scaloni A., Caira S., Leone M. The antimicrobial peptides casocidins I and II: Solution structural studies in water and different membrane-mimetic environments. Peptides. 2019;114:50–58. doi: 10.1016/j.peptides.2018.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.peptides.2018.09.004</ArticleId><ArticleId IdType="pubmed">30243923</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei Z., Wang H., Zhao Z., Chen X., Huan C., Zhang W. Chemokine PF4 Inhibits EV71 and CA16 Infections at the Entry Stage. J. Virol. 2022;96:e0043522. doi: 10.1128/jvi.00435-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00435-22</ArticleId><ArticleId IdType="pmc">PMC9175630</ArticleId><ArticleId IdType="pubmed">35579435</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang M., Wang X., Wang Q., Wang Y., Lin J., Sun Y., Li X., Zhang L., Lou Z., Wang J., et al. Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell. 2014;5:692–703. doi: 10.1007/s13238-014-0087-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-014-0087-3</ArticleId><ArticleId IdType="pmc">PMC4145081</ArticleId><ArticleId IdType="pubmed">24986489</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinkenberger N., Schoggins J.W. Mucolipin-2 cation channel increases trafficking efficiency of endocytosed viruses. mBio. 2018;9:e02314–e02317. doi: 10.1128/mBio.02314-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02314-17</ArticleId><ArticleId IdType="pmc">PMC5790917</ArticleId><ArticleId IdType="pubmed">29382735</ArticleId></ArticleIdList></Reference><Reference><Citation>Karasneh G.A., Shukla D. Herpes simplex virus infects most cell types in vitro: Clues to its success. Virol. J. 2011;8:481–492. doi: 10.1186/1743-422X-8-481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-481</ArticleId><ArticleId IdType="pmc">PMC3223518</ArticleId><ArticleId IdType="pubmed">22029482</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Li J., Hong Y., Jiang C., Wu J., Wu M., Sheng R., Liu H., Sun J., Xin Y., et al. Antiviral effects of the petroleum ether extract of Tournefortia sibirica L. against enterovirus 71 infection in vitro and in vivo. Front. Pharmacol. 2022;13:999798. doi: 10.3389/fphar.2022.999798.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.999798</ArticleId><ArticleId IdType="pmc">PMC9744809</ArticleId><ArticleId IdType="pubmed">36523495</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitas E.D., Bataglioli R.A., Oshodi J., Beppu M.M. Antimicrobial peptides and their potential application in antiviral coating agents. Colloids Surf. B Biointerfaces. 2022;217:112693. doi: 10.1016/j.colsurfb.2022.112693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.colsurfb.2022.112693</ArticleId><ArticleId IdType="pmc">PMC9262651</ArticleId><ArticleId IdType="pubmed">35853393</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Wang G. Insights into antimicrobial peptides from spiders and scorpions. Protein Pept. Lett. 2016;23:707–721. doi: 10.2174/0929866523666160511151320.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929866523666160511151320</ArticleId><ArticleId IdType="pmc">PMC4967028</ArticleId><ArticleId IdType="pubmed">27165405</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J., Dai Y., Fu Y., Wang K., Yang Y., Li M., Xu W., Wei L. Cathelicidin antimicrobial peptides suppress EV71 infection via regulating antiviral response and inhibiting viral binding. Antivir. Res. 2021;187:105021. doi: 10.1016/j.antiviral.2021.105021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2021.105021</ArticleId><ArticleId IdType="pubmed">33508330</ArticleId></ArticleIdList></Reference><Reference><Citation>El Hidan M.A., Laaradia M.A., El Hiba O., Draoui A., Aimrane A., Kahime K. Scorpion-derived antiviral peptides with a special focus on medically important viruses: An update. Biomed. Res. Int. 2021;2021:9998420. doi: 10.1155/2021/9998420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/9998420</ArticleId><ArticleId IdType="pmc">PMC8437663</ArticleId><ArticleId IdType="pubmed">34527748</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Fujii K., Koike S. Receptors for enterovirus 71. Emerg. Microbes Infect. 2014;3:e53. doi: 10.1038/emi.2014.49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2014.49</ArticleId><ArticleId IdType="pmc">PMC4126179</ArticleId><ArticleId IdType="pubmed">26038749</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>